by John W. Mitchell
, Senior Correspondent | February 20, 2017
In a stirring keynote address to a capacity crowd of 6,000 at the 2017 HIMSS conference, IBM chairman, president and CEO Ginni Rometty said that the time is right to solve some of the world’s greatest problems.
Despite the political and social change that might have a serious impact on health care, she told the group there is reason to be optimistic.
“I feel so profoundly hopeful,” said Rometty. “I think we’re at a time to reinvent and transform health care to an era of personalized medicine.”
KA Imaging’s Reveal 35C detector, currently available as an upgrade solution in the US and selected geographies, can now be sold in the European Union. The detector recently obtained the CE Mark. Contact us at firstname.lastname@example.org to book a free demo.
According to Rometty, cognitive use of big data to develop artificial intelligence has become mainstream, is here to stay, and amounts to a “moon shot.”
The pieces are in place for these technologies to take hold and have a larger influence on health care worldwide. Rometty noted, for example, that about 14 million new cases of cancer are diagnosed annually — and in the next few years that number is expected to grow to 20 million, many in developing nations.
“There is one oncologist for every 1,699 patients in India,” she said, citing the need for doctors to be able work faster and with better results, and also making a case for her company's own IBM’s Watson. “What used to take 20 minutes of patient information for a doctor to gather now takes 20 seconds with Watson.”
And, based on a recent study, Watson can find clinically actionable items in a medical record 30 percent more often than physicians alone. But even with this result, she stressed that it is not the role of AI such as Watson to replace doctors, but to serve as another diagnostic asset.
IBM made a slew of announcements to coincide with their CEO’s address, many related to Watson.
- Watson Health will debut Watson Clinical Imaging Review, the first cognitive imaging offering from IBM. The platform reviews medical data, including images (about 90 percent of all health care files, according to Rometty) to help health care providers identify the most critical cases that require attention. The first application, as reported after RSNA, targets aortic stenosis (AS).
- IBM will work with the Central New York Care Collaborative to create the nation’s first cognitive population health platform. The initiative is intended to connect more than 2,000 care providers across six counties, improve patient health and reduce costs in the state’s Medicaid system through reduced hospital stays by 25 percent over five years.
- IBM and Massachusetts-based Atrius Health, a fully-transitioned value-based provider group, will create a new Watson offering for primary care physicians to get more from their existing electronic health record.
- The company announced the expansion of the Watson Health medical imaging collaborative to 24 organizations worldwide, adding clinical and industry expertise for the worldwide initiative already tackling eye, brain, breast, heart and related conditions. The Watson Health medical imaging collaborative is an initiative comprising leading health systems, academic medical centers, private radiology practices, ambulatory radiology providers, and imaging technology companies, that are finding ways to use medical imaging to identify and predict the risk of cancer, diabetes, and diseases of the eye, brain and heart, and related conditions.